(Press-News.org) LEXINGTON, Ky. (Jan. 12, 2024) — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected to serve as co-chair of The Kentucky Heart Disease and Stroke Prevention (KHDSP) Task Force representing stroke systems of care across the state.
Goldstein is co-director of the Kentucky Neuroscience Institute, co-director of the UK Neuroscience Research Priority Area, contact PI for the state’s CDC Coverdell National Acute Stroke Program grant, and interim director of the UK-Norton Healthcare Stroke Care Network. Additionally, he also sits on the board of directors of The American Academy of Neurology (AAN).
With his focus on the stroke systems of care throughout Kentucky, Goldstein will lead the task force alongside Nathan Kusterer, M.D., a cardiologist with Baptist Health, who represents the state’s heart systems of care.
The task force works in partnership with the Kentucky Department for Public Health’s Heart Disease and Stroke Prevention Program. The collaborative group was developed in 2006 to address cardiovascular disease in the Commonwealth. The task force is comprised of a diverse group of stakeholders committed to improving the health of Kentuckians. The initial membership included 27 individuals representing 14 agencies; the task force currently has 419 members representing 194 different agencies.
“Through our work on Kentucky's CDC Coverdell National Acute Stroke Program, I have been working with the KHDSP Task Force to advance stroke prevention and care throughout Kentucky,” said Goldstein. “This is another opportunity to coordinate and leverage efforts to reduce the burden of stroke statewide.”
The task force is represented by health systems, emergency medical organizations, community-based, professional and voluntary health organizations, businesses, higher level educational institutes and local and state government agencies.
“The KHDSP brings together stroke and heart disease expertise and efforts to impact both conditions across the state. It is a particularly important approach for improving public health by addressing commonalities between heart disease and stroke,” said Goldstein.
The goal of the Task Force is to improve Kentucky’s cardiovascular and cerebrovascular health. “It is wonderful to have the opportunity to lead and work with a group of passionate, dedicated colleagues focused on making our state healthier,” said Goldstein.
UK HealthCare is the hospitals and clinics of the University of Kentucky. But it is so much more. It is more than 10,000 dedicated health care professionals committed to providing advanced subspecialty care for the most critically injured and ill patients from the Commonwealth and beyond. It also is the home of the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, a Level IV Neonatal Intensive Care Unit that cares for the tiniest and sickest newborns, the region’s only Level 1 trauma center and Kentucky’s top hospital ranked by U.S. News & World Report.
As an academic research institution, we are continuously pursuing the next generation of cures, treatments, protocols and policies. Our discoveries have the potential to change what’s medically possible within our lifetimes. Our educators and thought leaders are transforming the health care landscape as our six health professions colleges teach the next generation of doctors, nurses, pharmacists and other health care professionals, spreading the highest standards of care. UK HealthCare is the power of advanced medicine committed to creating a healthier Kentucky, now and for generations to come.
END
Goldstein selected to help lead statewide task force addressing heart disease and stroke
2024-01-12
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Healthy Hearts for Women event marks 10 years of raising awareness
2024-01-12
LEXINGTON, Ky. (Jan. 12, 2024) — The University of Kentucky will mark a decade of raising awareness and continuing its effort to warn women about the dangers of heart disease with the annual Healthy Hearts for Women Symposium.
Cardiovascular disease is the No. 1 killer of women, causing 1 in 3 deaths each year, according to the American Heart Association. Yet, only 44% of women recognize that cardiovascular disease is their greatest health threat.
“We see the evidence of this devastating statistic right here in Kentucky. The Commonwealth has the highest rates of deaths due to cardiovascular disease in women ...
Building trust and saving lives: A community approach to genetic education
2024-01-12
Changes to DNA, known as mutations, can increase the likelihood of developing cancer. Specifically, people with mutations in their BRCA 1 and 2 genes are substantially more likely to develop hereditary breast and ovarian cancers. But how do people know if they have these mutations?
Genetic testing.
Genetic testing allows doctors to see these microscopic changes. Knowing these mutations exist, doctors will check for signs of breast and ovarian cancers more often.
Yet minorities, especially Black women, are less likely to participate in genetic testing. ...
Using idle trucks to power the grid with clean energy
2024-01-12
University of Waterloo researchers are tapping into idled electric vehicles to act as mobile generators and help power overworked and aging electricity grids.
After analyzing energy demand on Alberta’s power grid during rush hour, the research proposes an innovative way to replenish electrical grids with power generated from fuel cells in trucks.
“Canada’s power grids need to be upgraded,” said Dr. XiaoYu Wu, lead researcher and a professor in Waterloo’s Department of Mechanical and Mechatronics Engineering.
“But the price ...
Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
2024-01-12
“Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma.”
BUFFALO, NY- January 12, 2024 – A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.”
Pazopanib, a multi-kinase VEGF inhibitor, is currently FDA approved for advanced renal cell carcinoma and advanced soft tissue sarcoma; but limited evidence exists on its efficacy in bone sarcomas.
In this case report, researchers Mohamed A. Gouda, ...
3D in vitro human atherosclerosis model for high-throughput drug screening
2024-01-12
BIRMINGHAM, Ala. – A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied for developing a high-throughput functional assay of drug candidates to treat this disease, University of Alabama at Birmingham researchers report in the journal Biomaterials.
“Current in vitro atherosclerosis models have significant limitations, including the lack of three-layer vascular architecture and limited atherosclerotic features,” said Ho-Wook Jun, Ph.D., a professor ...
The early bird (or scientist) gets the worm
2024-01-12
RIVERSIDE, Calif. -- Size does not matter. Certainly not when it comes to tiny worms securing the attention of biologists. One such biologist, Morris F. Maduro at the University of California, Riverside, has just been awarded a grant of nearly $1.3 million from the National Science Foundation, or NSF, to study a worm (or nematode) about a millimeter in length.
The research project will focus on the gut of Pristionchus pacificus. Like most nematodes, P. pacificus develops quickly, its growth from embryo to adult taking just four days. It is a complete ...
News media trigger conflict for romantic couples with differing political views
2024-01-12
CHAMPAIGN, Ill. — By one estimate, as many as 30% of people in the U.S. are in romantic relationships with partners who do not share their political views. In today’s hyperpartisan climate, where Democrats and Republicans have difficulty talking to each other and their views are polarized about media outlets’ credibility, how do couples with differing political perspectives decide which media to follow? And how do these decisions affect their discussions on political issues and their relationship ...
Earth-sized planet discovered in ‘our solar backyard’
2024-01-12
MADISON — A team of astronomers have discovered a planet closer and younger than any other Earth-sized world yet identified. It’s a remarkably hot world whose proximity to our own planet and to a star like our sun mark it as a unique opportunity to study how planets evolve.
The new planet was described in a new study published this week by The Astronomical Journal. Melinda Soares-Furtado, a NASA Hubble Fellow at the University of Wisconsin–Madison who will begin work as an astronomy professor at the university in the fall, and recent UW–Madison graduate Benjamin Capistrant, now a graduate student at the University of Florida, co-led the study with co-authors from ...
NASA analysis confirms 2023 as warmest year on record
2024-01-12
Earth’s average surface temperature in 2023 was the warmest on record, according to an analysis by NASA. Global temperatures last year were around 2.1 degrees Fahrenheit (1.2 degrees Celsius) above the average for NASA’s baseline period (1951-1980), scientists from NASA’s Goddard Institute for Space Studies (GISS) in New York reported.
“NASA and NOAA’s global temperature report confirms what billions of people around the world experienced last year; we are facing a climate ...
Incontinence could point to future disability
2024-01-12
If you are one of the 30% to 50% of women experiencing urinary incontinence, new research suggests that it could turn into a bigger health issue.
Having more frequent urinary incontinence and leakage amounts is associated with higher odds of disability, according to RUSH researchers in a study published in the January issue of Menopause.
“Often symptoms from urinary incontinence are ignored until they become bothersome or limit physical or social activities,” said Sheila Dugan, MD, chair of the Department of Physical Medicine and Rehabilitation at RUSH. “Because this study suggests that urinary incontinence is associated with disability, ...